U.S. military orders review as anthrax mishap widens | Improving antibiotic stewardship through better diagnostics | Kansas hospital monitoring patient for possible Ebola infection | Global eradication: Is measles next? | The most predictable disaster in the history of the human race | Groundbreaking for new Biosafety Level 4 lab in Kansas | On the Department of Defense’s anthrax shipments | Feds release resources for respiratory protection of health workers | Foreseeing an economic boom, Manhattan, Kan., opens its arms to new lab | Surveillance of acute respiratory infections with molecular diagnostic testing | Bavarian Nordic not for sale after big pharma deals | Next-generation sequencing aids in fight against Ebola virus | WHO considers measures to quicken outbreak response | Lassa fever carries little risk to public, experts say | USDA chief vet says bird flu cases waning, sees end by July | Why there’s no need to panic over Lassa fever | Plant biosecurity course at BRI combats wheat blast | Effectiveness of powered air purifying respirators in health care | Anthrax inquiry widens to 24 labs in 11 states, two foreign countries | Principles and challenges in access to experimental medicines | China has first MERS case as Korean cluster grows further | Stronger regulation of toxic chemicals
See what we’re reading this week at Global Biodefense on topics including the DoD live anthrax shipments, new BSL4 lab in Kansas, and MERS in Korea.
Global eradication: Is measles next? (Science)
On the Department of Defense’s anthrax shipments (Bifurcated Needle)
Why there’s no need to panic over Lassa fever (Washington Post)
Stronger regulation of toxic chemicals (NY Times)